Invitrogen's PD-Direct is a fully integrated service for customised bioprocess development, and is the subject of a technology tutorial on developing novel types of CHO cells
The technology tutorial on developing novel types of CHO cells takes at 12.35 on Tuesday 4 March in the main hall of the European Cell Line Development and Engineering Conference in Prague.
The presentation, 'Engineering of novel platform cell lines with phenotypic traits advantageous for bioproduction', will help scientists understand how Invitrogen is using its PD-Direct Revolution technology.
Jonathan Dempsey, process science fellow at Invitrogen PD-Direct, a scientist with many years experience in developing cell culture manufacturing processes and cell lines, will discuss how Revolution enables optimisation of CHO cells by accelerating gene evolution.
This combined with screening and selection techniques can produce cells resistant to high osmolality and therefore better adapted to large scale bioprocess.
As an added bonus, those that wish to attend the Invitrogen tutorial at European Cell Line Development and Engineering can email Holly Williams on holly.williams@informa.com and quote the Invitrogen promotional code of TT39 to obtain a 25% discount on the cost of conference registration.
Jonathan Dempsey, process science fellow at Invitrogen PD-Direct, said: "In recent years, cutting development time to produce profitable biopharmaceuticals is becoming critical for many pharma and biotechs companies.
"I'm looking forward to presenting the data and to discussing the benefits of using Revolution for generating cell lines with improved phenotypic traits for bioprocessing at our technology tutorial at European Cell Line Development and Engineering in Prague, because optimising the host cell line promises to be a powerful new approach to improving large scale bioprocessing".
